• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    BioOptics Stock Watch
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries

    DexCom, Inc. - Common Stock (NQ:DXCM)

    72.61 +1.38 (+1.94%)
    Streaming Delayed Price Updated: 10:59 AM EDT, Jun 18, 2026 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 1,590,529
    Open 72.61
    Bid (Size) 72.57 (100)
    Ask (Size) 72.67 (100)
    Prev. Close 71.23
    Today's Range 71.60 - 73.69
    52wk Range 54.11 - 89.98
    Shares Outstanding 384,800,000
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    News headline image
    3 Stocks Doing the Heavy Lifting in Healthcare’s Rebound ↗
    Led by Eli Lilly’s GLP-1 success, Humana’s expanding margins, and DexCom’s medtech growth, the healthcare sector is staging a major market rebound. 
    Via MarketBeat
    News headline image
    1 Cash-Producing Stock with Impressive Fundamentals and 2 We Find Risky
    While strong cash flow is a key indicator of stability, it doesn’t always translate to superior returns. Some cash-heavy businesses struggle with inefficient... 
    Via StockStory

    Performance

    YTD
    +9.1%
    +9.1%
    1 Month
    +11.6%
    +11.6%
    3 Month
    +7.3%
    +7.3%
    6 Month
    +10.4%
    +10.4%
    1 Year
    -11.3%
    -11.3%

    More News

    Read More
    News headline image
    3 Reasons Investors Love DexCom (DXCM)
    Via StockStory
    Topics Stocks
    News headline image
    1 Surging Stock with Impressive Fundamentals and 2 That Underwhelm
    Via StockStory
    DexCom Inc (NASDAQ:DXCM) Passes Rigorous Quality Screen with Strong Profitability and Growth Metrics ↗
    Via Chartmill
    These S&P500 stocks have an unusual volume in today's session ↗
    Via Chartmill
    News headline image
    Dexcom CONNECT Study: The Most Significant Clinical Study Demonstrating CGM Benefits for People with Type 2 Diabetes Not Using Insulin
    From DexCom, Inc.
    Via Business Wire
    News headline image
    DexCom vs. Insulet: Which Diabetes Stock Is a Better Buy in 2026? ↗
    Via The Motley Fool
    News headline image
    Dexcom Reaffirms CGM Benefits for All People With Diabetes and Continues Momentum Toward Earlier Stage Intervention and Preventative Care at ADA 2026
    From Dexcom
    Via Business Wire
    News headline image
    2 Growth Stocks to Buy and Hold for a Decade ↗
    Via The Motley Fool
    Topics Artificial Intelligence Stocks
    News headline image
    Dexcom Releases Customer Advisory Council Report, Outlining Ongoing Commitments to Enhancing Product Performance and User Experience
    From Dexcom
    Via Business Wire
    News headline image
    Dexcom Uncovers Theft of Scrapped Product, Notifies Potentially Impacted Users
    From DexCom, Inc.
    Via Business Wire
    Stay informed with the top movers within the S&P500 index on Tuesday. ↗
    Via Chartmill
    News headline image
    Redefining CGM for People With Type 2 Diabetes: Dexcom Announces Dexcom Flex in Germany
    From DexCom, Inc.
    Via Business Wire
    News headline image
    DexCom Maps G8 Launch, Coverage Expansion and Double-Digit Growth at Investor Day ↗
    Via MarketBeat
    What's going on in today's session: S&P500 movers ↗
    Via Chartmill
    Uncover the latest developments among S&P500 stocks in today's session. ↗
    Via Chartmill
    News headline image
    Dexcom Announces Governance Enhancements Ahead of 2026 Investor Day
    From DexCom, Inc.
    Via Business Wire
    News headline image
    Sell in May and Go Away—Starting With These 3 Stocks ↗
    Via MarketBeat
    Topics Artificial Intelligence
    News headline image
    2 Mid-Cap Stocks with Impressive Fundamentals and 1 We Question
    Via StockStory
    News headline image
    3 Quality Compounders Worth Your Attention
    Via StockStory
    News headline image
    5 Insightful Analyst Questions From DexCom’s Q1 Earnings Call
    Via StockStory
    Topics Earnings Economy
    News headline image
    3 Reasons Analysts Love DexCom ↗
    Via MarketBeat
    News headline image
    Dexcom to Host Investor Day on May 14, 2026
    From DexCom, Inc.
    Via Business Wire
    Friday's session: gap up and gap down stock in the S&P500 index ↗
    Via Chartmill

    Frequently Asked Questions

    Is DexCom, Inc. - Common Stock publicly traded?
    Yes, DexCom, Inc. - Common Stock is publicly traded.
    What exchange does DexCom, Inc. - Common Stock trade on?
    DexCom, Inc. - Common Stock trades on the Nasdaq Stock Market
    What is the ticker symbol for DexCom, Inc. - Common Stock?
    The ticker symbol for DexCom, Inc. - Common Stock is DXCM on the Nasdaq Stock Market
    What is the current price of DexCom, Inc. - Common Stock?
    The current price of DexCom, Inc. - Common Stock is 72.61
    When was DexCom, Inc. - Common Stock last traded?
    The last trade of DexCom, Inc. - Common Stock was at 06/18/26 10:59 AM ET
    What is the market capitalization of DexCom, Inc. - Common Stock?
    The market capitalization of DexCom, Inc. - Common Stock is 27.94B
    How many shares of DexCom, Inc. - Common Stock are outstanding?
    DexCom, Inc. - Common Stock has 28B shares outstanding.
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the Privacy Policy and Terms Of Service.
    © 2025 FinancialContent. All rights reserved.